Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil T Parkin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
AIDS Reviews|September 16, 2014
Measurement of HIV-1 viral load for drug resistance surveillance using dried blood spots: literature review and modeling of contribution of DNA and RNANeil T Parkin
Antiviral Therapy|March 26, 2004
Antiretroviral drug resistance in non-subtype B HIV-1, HIV-2 and SIVNeil T Parkin, Jonathan M Schapiro
AIDS (London, England)|April 18, 2003
Improving lopinavir genotype algorithm through phenotype correlations: novel mutation patterns and amprenavir cross-resistanceNeil T Parkin, Colombe Chappey, Christos J Petropoulos
Antiviral Chemistry & Chemotherapy|October 26, 2005
In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIsRichard C Bethell, Yolanda S Lie, Neil T Parkin
Antimicrobial Agents and Chemotherapy|December 27, 2005
The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitorsNeil T Parkin, Soumi Gupta, Colombe Chappey, et al.
Antiviral Therapy|May 29, 2008
Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial databaseDamian J McColl, Colombe Chappey, Neil T Parkin, et al.
AIDS Reviews|December 24, 2010
Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillanceSilvia Bertagnolio, Neil T Parkin, Michael Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failureJulia G Prado, Neil T Parkin, Bonaventura Clotet, et al.
Science (New York, N.Y.)|November 30, 2004
Evidence for positive epistasis in HIV-1Sebastian Bonhoeffer, Colombe Chappey, Neil T Parkin, et al.
The Journal of Infectious Diseases|September 27, 2003
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolatesJeannette M Whitcomb, Neil T Parkin, Colombe Chappey, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
AIDS Reviews|September 16, 2014
Measurement of HIV-1 viral load for drug resistance surveillance using dried blood spots: literature review and modeling of contribution of DNA and RNANeil T Parkin
Antiviral Therapy|March 26, 2004
Antiretroviral drug resistance in non-subtype B HIV-1, HIV-2 and SIVNeil T Parkin, Jonathan M Schapiro
AIDS (London, England)|April 18, 2003
Improving lopinavir genotype algorithm through phenotype correlations: novel mutation patterns and amprenavir cross-resistanceNeil T Parkin, Colombe Chappey, Christos J Petropoulos
Antiviral Chemistry & Chemotherapy|October 26, 2005
In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIsRichard C Bethell, Yolanda S Lie, Neil T Parkin
Antimicrobial Agents and Chemotherapy|December 27, 2005
The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitorsNeil T Parkin, Soumi Gupta, Colombe Chappey, et al.
Antiviral Therapy|May 29, 2008
Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial databaseDamian J McColl, Colombe Chappey, Neil T Parkin, et al.
AIDS Reviews|December 24, 2010
Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillanceSilvia Bertagnolio, Neil T Parkin, Michael Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failureJulia G Prado, Neil T Parkin, Bonaventura Clotet, et al.
Science (New York, N.Y.)|November 30, 2004
Evidence for positive epistasis in HIV-1Sebastian Bonhoeffer, Colombe Chappey, Neil T Parkin, et al.
The Journal of Infectious Diseases|September 27, 2003
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolatesJeannette M Whitcomb, Neil T Parkin, Colombe Chappey, et al.
Pageof 4